Are BioSpecifics Shareholders Getting Enough in the Endo Buyout?
Are BioSpecific Technologies shareholders actually getting a good deal from the merger agreement with Endo International?
Are BioSpecific Technologies shareholders actually getting a good deal from the merger agreement with Endo International?
OraSure Technologies shares jumped to start off the week after the company announced an update from the FDA in regards to its COVID-19 test kit.
The number of confirmed COVID-19 cases in the United States recently has risen so much that the county has entered what is being called a "third wave." Still, the hardest-hit day so far was…
Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After all, many investors missed the bulk of the recovery from March’s panic selling lows.…
While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s CEO has provided an update on their COVID-19 vaccine.
Global confirmed cases of COVID-19 have reached 38.9 million, and fatalities from the disease have reached nearly 1.1 million.
The spread of COVID-19 has been particularly aggressive in parts of the South. The hardest-hit county in America is in Georgia.
Global confirmed cases of COVID-19 have reached 38.5 million. At the current rate, global deaths will reach 1.1 million within days.
COVID-19 is spreading like wildfire through some parts of the nation, particularly in the South. The hardest-hit county in America is in Georgia.
Taiwan Liposome has enrolled its first subject for its coronavirus treatment that includes the controversial hydroxychloroquine.
When cash is king, selling off a portion of the business or finding a way to raise capital can be crucial to continuing operations.
UnitedHealth posted better than expected third-quarter financial results before the markets opened on Wednesday, but shares retreated afterward.
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Global confirmed cases of COVID-19 have reached 38.1 million. Global deaths from the disease are expected to reach 1.1 million within days.
Gossamer Bio shares dived on Tuesday after the company announced midstage results from its asthma and chronic rhinosinusitis studies.